Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MilkCPP is a biotechnology company focused on developing a novel drug delivery platform based on cell-penetrating peptides (CPPs) derived from bovine milk proteins. The company's technology leverages the natural ability of these milk-derived sequences to cross biological barriers, including the cell membrane and potentially the blood-brain barrier, to deliver therapeutic cargoes such as small molecules, proteins, and nucleic acids. By utilizing bio-inspired, non-toxic, and highly efficient delivery vectors, MilkCPP aims to enhance the bioavailability and efficacy of treatments for oncology and inflammatory conditions. The platform represents a significant advancement in overcoming the delivery challenges associated with intracellular drug targets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MilkCPP.